Abstract:ABSTRACT The detection of Clostridioides difficile infections (CDI) relies on testing the stool of patients by toxin antigen detection or PCR methods. Although PCR and antigenic methods have significantly reduced the time to results, delays in stool collection can significantly add to the turnaround time. The use of rectal swabs to detect C. difficile could considerably reduce the time to diagnosis of CDI. We developed a new rapid PCR assay for the detection of C. difficile and evaluated this PCR assay on both stool and rectal swab specimens. We recruited a total of 623 patients suspected of C. difficile infection. Stool samples and rectal swabs were collected from each patient and tested by our PCR assay. Stool samples were also tested by the cell cytotoxicity neutralization assay (CCNA) as a reference. The PCR assay detected C. difficile in 60 stool specimens and 61 rectal swabs for the 64 patients whose stool samples were positive for C. difficile by CCNA. The PCR assay detected an additional 35 and 36 stool and rectal swab specimens positive for C. difficile , respectively, for sensitivity with stools and rectal swabs of 93.8% and 95.3%, specificity of 93.7% and 93.6%, positive predictive values of 63.2% and 62.9%, and negative predictive values of 99.2% and 99.4%. Detection of C. difficile using PCR on stools or rectal swabs yielded reliable and similar results. The use of PCR tests on rectal swabs could reduce turnaround time for CDI detection, thus improving CDI management and control of C. difficile transmission. IMPORTANCE Clostridioides difficile infection (CDI) is the leading cause of healthcare-associated diarrhea, resulting in high morbidity, mortality, and economic burden. In clinical laboratories, CDI testing is currently performed on stool samples collected from patients with diarrhea. However, the diagnosis of CDI can be delayed by the time required to collect stool samples. Barriers to sample collection could be overcome by using a rectal swab instead of a stool sample. Our study showed that CDI can be identified rapidly and reliably by a new PCR assay developed in our laboratory on both stool and rectal swab specimens. The use of PCR tests on rectal swabs could reduce the time for the detection of CDI and improve the management of this infection. It should also provide a useful alternative for infection-control practitioners to better control the spread of C. difficile .

Clinical evaluation of GeneXpert real-time fluorescence quantitation PCR in rapid detection of Clostridium difficile

Real - Time Fluorescence PCR Assay to Detect Staphyloccus Aureus Enterotoxins A and D in Fecal Samples

Applicability of Commercial Multiplex Kit for the Diagnosis Of: a Multicenter Investigation Clostridium Difficile Infections

Assessment Of Clostridium Difficile Infections By Quantitative Detection Of Tcdb Toxin By Use Of A Real-Time Cell Analysis System

A rapid multiplex real-time PCR detection of toxigenic Clostridioides difficile directly from fecal samples

Clinical evaluation of three methods in detection of Clost ridium difficile in stool

Comparison of Two Molecular Methods for Detecting Toxigenic Clostridium Difficile.

Comparison of a Commercial Multiplex Real-Time PCR to the Cell Cytotoxicity Neutralization Assay for Diagnosis of Clostridium Difficile Infections

Comparison of rectal swabs and fecal samples for the detection of Clostridioides difficile infections with a new in-house PCR assay

Development and Clinical Application of a Rapid, Visually Interpretable Polymerase Spiral Reaction for Tcdb Gene of Clostridioides Difficile in Fecal Cultures.

Rapid visualization of Clostridioides difficile toxins A and B by multiplex RPA combined with CRISPR-Cas12a

[Evaluation of the Clinical Validity of the Clostridioides difficile Nucleic Acid Detection Kit "Smart Gene® CD ToxinB"]

Rapid discrimination between clinical Clostridioides difficile infection and colonization by quantitative detection of TcdB toxin using a real-time cell analysis system

Comparison of Microdroplet Digital PCR Assays with Real-time Fluorescence Quantitative PCR for Clostridioides difficile Detection.

Development and evaluation of a rapid visual loop-mediated isothermal amplification assay for the tcdA gene in Clostridioides difficile detection

Novel target and PCR assay for identification of hypervirulent ST1 (BI/NAP1/027) Clostridioides difficile and detection of toxigenic C. Difficile

Detection of Clostridium difficile toxins A and B in inpatient stool samples by enzyme-linked fluorescent immunoassay

Establishment of Quantifying and Typing Analysis of 16S Rrna Gene by Real-Time PCR

Rapid Identification of Clostridium Difficile in Stool Sample by Fluorescence in Situ Hybridization

Toxicity-Based Typing of Clostridioides Difficile by Loop-Mediated Isothermal Amplification (LAMP) in Critically Ill Patients

Clostridium difficile PCR Cycle Threshold Predicts Free Toxin